We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDSTW
1851
CALL
Stardust Power Inc Warrant
SDSTW
$4.71M
$1.53M ﹤0.01%
151,433
MOBV
1852
DELISTED
Mobiv Acquisition Corp Class A Common Stock
MOBV
$1.53M ﹤0.01%
144,310
MOBVW
1853
CALL
DELISTED
Mobiv Acquisition Corp Warrant
MOBVW
$1.53M ﹤0.01%
144,310
PNTG icon
1854
Pennant Group
PNTG
$1.46B
$1.53M ﹤0.01%
+139,124
New +$1.51M
GLTA.WS
1855
CALL
DELISTED
Galata Acquisition Corp. Warrants, each whole warrant exercisable for one class A ordinary share at an exercise price of $11.50
GLTA.WS
$1.53M ﹤0.01%
148,185
MMM icon
1856
CALL
3M
MMM
$93.1B
$1.52M ﹤0.01%
+15,189
New +$1.55M
AMBP icon
1857
Ardagh Metal Packaging
AMBP
$2.96B
$1.52M ﹤0.01%
+315,231
New +$1.45M
MYOV
1858
DELISTED
Myovant Sciences Ltd.
MYOV
$1.52M ﹤0.01%
56,200
+20,117
+56% +$529K
TIOAW
1859
CALL
DELISTED
Tio Tech A Warrants
TIOAW
$1.51M ﹤0.01%
149,994
STRE.WS
1860
CALL
DELISTED
Supernova Partners Acquisition Company III, Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
STRE.WS
$1.51M ﹤0.01%
149,995
HROW icon
1861
Harrow
HROW
$1.46B
$1.51M ﹤0.01%
102,030
+75,031
+278% +$897K
FZT.WS
1862
CALL
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
$1.5M ﹤0.01%
149,997
CAMT icon
1863
Camtek
CAMT
$6.16B
$1.5M ﹤0.01%
+68,366
New +$1.58M
FXB icon
1864
Invesco CurrencyShares British Pound Sterling Trust
FXB
$76.8M
$1.5M ﹤0.01%
12,923
+12,896
+47,763% +$1.46M
TRTL.WS
1865
CALL
DELISTED
TortoiseEcofin Acquisition Corp. III Warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TRTL.WS
$1.49M ﹤0.01%
150,194
SEDA
1866
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$1.49M ﹤0.01%
148,482
GFI icon
1867
Gold Fields
GFI
$28.6B
$1.49M ﹤0.01%
144,246
-134,469
-48% -$1.3M
RCACW
1868
CALL
DELISTED
Revelstone Capital Acquisition Corp. Warrant
RCACW
$1.49M ﹤0.01%
148,514
INVX
1869
Innovex International
INVX
$1.79B
$1.49M ﹤0.01%
54,806
+43,854
+400% +$1.04M
JAQCW
1870
CALL
DELISTED
Jupiter Acquisition Corporation Warrants
JAQCW
$1.49M ﹤0.01%
148,289
AMC icon
1871
AMC Entertainment Holdings
AMC
$2.36B
$1.48M ﹤0.01%
+36,481
New +$2.3M
RNAC icon
1872
Cartesian Therapeutics
RNAC
$224M
$1.48M ﹤0.01%
43,681
-17,955
-29% -$764K
TUR icon
1873
iShares MSCI Turkey ETF
TUR
$200M
$1.48M ﹤0.01%
39,997
-30,874
-44% -$945K
BMTX.WS
1874
CALL
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$1.47M ﹤0.01%
281,867
-10,196
-3% -$7.25K
INVA icon
1875
Innoviva
INVA
$1.6B
$1.47M ﹤0.01%
110,691
-285,176
-72% -$3.75M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.